Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
G Ital Med Lav Ergon ; 29(3 Suppl): 550-2, 2007.
Article in Italian | MEDLINE | ID: mdl-18409826

ABSTRACT

In several recent studies blood lead levels below 100 microg/L have been associated with reduced neurocognitive capacities and neurobehavioural performances in children, with no clear evidence of the lowest "safe" level not associated to adverse effects on the CNS. We analyzed blood lead concentration and the results of 5 neurocognitive tests, two derived from the Swedish Performance Evaluating System (SPES) and three from the Wechsler Intelligence Scale for Children-Revised (WISC-R), in 139 Sardinian adolescents living in Portoscuso, a town 2 Km far from a lead smelter, and in 72 age-matched students living in S. Antioco, a town about 15 Km far from the same smelter. The blood lead concentrations were lower than 100 microg/l in almost subjects, but, in average, significantly higher particularly among males, in the Portoscuso group compared to controls. The regression coefficients derived from the multivariate stepwise analysis, adjusted for the student's age and gender and for the educational and socio-economic level of parents, showed that reduced performances in neurocognitive test were significantly associated to increasing blood lead concentrations. According to previous our surveys in the same area and to the recent scientific literature on this topic, the present study suggests the need to further low the blood lead levels, considered by the U.S. CDC in 1991 as potentially "safe" for the children's CNS, to a threshold possibly < 50 microg/L.


Subject(s)
Environmental Exposure/analysis , Lead/blood , Adolescent , Adolescent Behavior/drug effects , Child , Female , Humans , Italy , Lead/pharmacology , Male , Nervous System/drug effects , Neuropsychological Tests
2.
G Ital Med Lav Ergon ; 29(3 Suppl): 824-7, 2007.
Article in Italian | MEDLINE | ID: mdl-18409983

ABSTRACT

Among 273 students (age 11-16 years) living in two small towns located respectively 2 (Portoscuso) and 15 kilometres (S. Antioco) far from the industrial area of Portovesme, the respiratory risk associated to cigarette smoking and environmental pollution was evaluated by the ISAAC questionnaire and standardized spirometry. The prevalence of parent's smoking was high in both groups (66.3% and 59.4%). Smoking during pregnancy was reported by 15% of mothers, without significant differences between the two schools. The prevalence of smokers among students was similar comparing the two groups (7% vs 6%). The prevalence of asthma in the whole population was significantly associated to skin positivity to common allergens, to the familiarity for asthma and to the environmental tobacco smoking, particularly if maternal. Spirometric values were significantly lower among students living in Portoscuso than among those of the S. Antioco school, with an evident interaction between the residential factor and the tobacco smoking, active and/or passive, in reducing the forced end- expiratory flows. Our results support the significant role of tobacco smoking, active and passive, particularly if derived from maternal smoking during pregnancy, in increasing the prevalence of respiratory disorders and lowering lung function in children. Living in Portoscuso, because of higher environmental exposure to airborne pollutants of industrial origin, has been shown as a relevant factor further lowering the lung function among the studied sample.


Subject(s)
Air Pollution/adverse effects , Respiration Disorders/epidemiology , Respiration Disorders/etiology , Smoking/adverse effects , Students , Tobacco Smoke Pollution/adverse effects , Adolescent , Child , Female , Humans , Italy , Male , Risk Factors
3.
Acta Otorhinolaryngol Ital ; 23(4): 322-5, 2003 Aug.
Article in English | MEDLINE | ID: mdl-15046423

ABSTRACT

The case is described of a Kikuchi-Fujimoto disease, in a 22-year-old female, onset of which was characterised by rapidly evolving lateral neck lymphadenopathy. Since clinico-radiological findings suggested a lymphoproliferative disease, it was mandatory, in order to establish the diagnosis and programme a suitable treatment protocol, to collect a lymph node biopsy specimen. The histological pattern was characteristic of Kikuchi-Fujimoto disease necrotizing lymphadenitis. Bearing in mind the difficulties encountered in the diagnosis of Kikuchi-Fujimoto disease, due not only to lack of a characteristic clinical pattern but also to the generic and aspecific findings emerging from radiological evaluation, the Authors stress the important role of histological examination in establishing the nature of the disease. In their opinion, onset of a rapidly evolving lateral neck lymphadenopathy, in a young patient, in the absence of well-defined disorders possibly responsible for the condition, and in order to establish a correct diagnostic approach, should induce the ENT specialist to take into consideration the possible presence of Kikuchi-Fujimoto disease, even if this is to be considered a rare finding.


Subject(s)
Histiocytic Necrotizing Lymphadenitis/pathology , Adult , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Biopsy, Needle , Diagnosis, Differential , Drug Therapy, Combination , Female , Histiocytic Necrotizing Lymphadenitis/drug therapy , Humans , Neck , Piperacillin/therapeutic use , Sulfonamides/therapeutic use
4.
Cancer ; 80(8): 1464-71, 1997 Oct 15.
Article in English | MEDLINE | ID: mdl-9338471

ABSTRACT

BACKGROUND: The aim of this study was to define the maximum tolerated doses (MTDs) of cisplatin (CDDP) and 5-fluorouracil (5-FU) administered as protracted intravenous infusion (PVI) during hyperfractionated radiotherapy (HFRT) administered with organ-sparing intent to patients with infiltrating transitional cell carcinoma of the bladder (TCCB). METHODS: Twenty-five patients with T2-T4aNXM0 TCCB were enrolled in this study. After a complete transurethral resection, bladder mapping, and two cycles of induction chemotherapy, patients were submitted to HFRT and CDDP + 5-FU as concomitant PVI at escalating dose levels until MTDs were reached. Treatment efficacy was also evaluated, in terms of complete response (CR) rates and cystectomy free, disease free, and overall survival. RESULTS: Combined treatment was well tolerated. The recommended doses for Phase II studies of PVI chemotherapy and radiotherapy for patients with invasive bladder carcinoma are CDDP 5 mg/m2/day and 5-FU 220 mg/m2/day. Twenty-four patients were evaluable for response: 21 (87.5%) had CR and 3 PR. After a median follow-up of 31 months (range, 11-49 months), 18 of 21 patients with CRs (86%) were alive: 15 (71.4%) had tumor free bladder, of whom 3 had superficial recurrence successfully treated with endovesical therapy and 1 had distant metastases. Three patients were submitted to cystectomy, one for superficial recurrence and hematuria and two for invasive bladder recurrence. CONCLUSIONS: This study defines the MTDs of CDDP and 5-FU concomitantly administered with hyperfractionated radiotherapy. The low toxicity observed and the high CRs and bladder preservation rates deserve further study.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Transitional Cell/therapy , Urinary Bladder Neoplasms/therapy , Aged , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Carcinoma, Transitional Cell/radiotherapy , Carcinoma, Transitional Cell/surgery , Cisplatin/administration & dosage , Cisplatin/adverse effects , Dose-Response Relationship, Drug , Female , Fluorouracil/administration & dosage , Fluorouracil/adverse effects , Humans , Infusions, Intravenous , Male , Methotrexate/administration & dosage , Middle Aged , Radiotherapy Dosage , Remission Induction , Urinary Bladder Neoplasms/drug therapy , Urinary Bladder Neoplasms/surgery , Vinblastine/administration & dosage
5.
Radiol Med ; 85(6): 831-5, 1993 Jun.
Article in Italian | MEDLINE | ID: mdl-8337442

ABSTRACT

Expert systems are application tools based on logic and containing a wide knowledge in a specific field; their aim is the simulation of an expert's behavior in reasoning and making decisions inherent a small cultural domain. Applications in medicine and radiology are numerous and constantly increasing. The possibility of their use in the application of diagnostic and staging protocols seems particularly interesting. The development and commercial availability of expert systems programming tools (called shells) make it certainly easier to develop consultations systems, even to non-experienced users. The purpose of this research is the definition and description of the stages encountered during the development of an expert system for diagnosis, staging and treatment of bladder cancer using self-developed shell, designed for radiological use, called Experto. The steps of knowledge collection, definition of diagnostic and therapeutic protocols and system development are described. The consultation system assessed the correct TNM stage of the 27 examined cases.


Subject(s)
Expert Systems , Urinary Bladder Neoplasms/pathology , Urinary Bladder Neoplasms/therapy , Decision Trees , Humans , Neoplasm Staging
SELECTION OF CITATIONS
SEARCH DETAIL
...